Category: Baxano SurgicalSyndicate content

Spine: Baxano Surgical closes $10M private placement

April 24, 2014 by Arezu Sarvestani

Baxano Surgical puts a ribbon on a private placement funding round after raising $10 million from unnamed investors.

Spine: Baxano Surgical closes $10M private placement

SafeStitch lures Baxano CFO Slattery to be new finance chief

September 25, 2013 by Brad Perriello

SafeStitch Medical lures Joseph Slattery to be its new CFO from Baxano, who names former Talecris Biotherapeutics exec Timothy Shannon as interim replacement.

SafeStitch lures Baxano CFO Slattery to be new finance chief
SafeStitch lures Baxano CFO Slattery to be new finance chief

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxano lowers full-year guidance amid widening losses, growing sales

August 14, 2013 by Arezu Sarvestani

Baxano fails to meet Wall Streets expectations during its 2nd quarter of 2013, during which the company reinvented itself as Baxano Surgical.

Baxano reinvents itself amid widening losses, growing sales

Baxano Surgical pays $6M to settle federal healthcare fraud beef

July 8, 2013 by Arezu Sarvestani

Baxano Surgical closes the books, without admitting wrong-doing, on a Justice Dept. investigation over allegations of healthcare fraud.

Baxano logo

Covidien CEO Almeida wants more from emerging markets | Wall Street Beat

June 11, 2013 by Arezu Sarvestani

Covidien's doubling down in emerging markets yet again, looking to invest in Brazil, South Africa and Mexico and other high-growth regions in hopes of hitting $2 billion in emerging market revenue "as soon as possible."

MassDevice.com Wall Street Beat

Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp